Skip to main content
. Author manuscript; available in PMC: 2009 Feb 1.
Published in final edited form as: J Neuroimmunol. 2008 Jan 10;194(1-2):83–88. doi: 10.1016/j.jneuroim.2007.11.019

Fig. 5. Atropine inhibits leukocyte migration in response to fMLP, and MCP-1.

Fig. 5

(A) Random migration (no chemoattractant) and fMLP-induced chemokinesis and chemotaxis of PBMC from (A) turpentine-treated (CON) and atropine-treated (AT) animals. (B) Random and MCP-1-induced migration of PBMC from CON and AT-treated animals. Bar graphs represent mean ± SEM (n = 6). *Significant change from CON (i.e., p ≤ 0.05).